Spinal co-administration of peptide substance P antagonist increases antinociceptive effect of the opioid peptide biphalin. 1994

K Misterek, and I Maszczynska, and A Dorociak, and S W Gumulka, and D B Carr, and S K Szyfelbein, and A W Lipkowski
Department of Pharmacodynamics, Medical Academy, Warsaw, Poland.

Intrathecal injection of 0.25 micrograms of undecapeptide substance P antagonist (SPA) produced transient antinociception with a peak effect at 5 min. Increasing the SPA dose resulted in neurotoxicity. Intrathecal injection of the opioid peptide biphalin (BIP) produced antinociception for over 3 hrs without neurotoxicity. Co-administration of SPA (at subtoxic doses) increased BIP's antinociceptive effect. Naltrexone reversed analgesia due to BIP alone as well as after BIP+SPA.

UI MeSH Term Description Entries
D007278 Injections, Spinal Introduction of therapeutic agents into the spinal region using a needle and syringe. Injections, Intraspinal,Injections, Intrathecal,Intraspinal Injections,Intrathecal Injections,Spinal Injections,Injection, Intraspinal,Injection, Intrathecal,Injection, Spinal,Intraspinal Injection,Intrathecal Injection,Spinal Injection
D008297 Male Males
D009271 Naltrexone Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. Antaxone,Celupan,EN-1639A,Nalorex,Naltrexone Hydrochloride,Nemexin,ReVia,Trexan,EN 1639A,EN1639A
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D010147 Pain Measurement Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies. Analgesia Tests,Analogue Pain Scale,Formalin Test,McGill Pain Questionnaire,Nociception Tests,Pain Assessment,Pain Intensity,Pain Severity,Tourniquet Pain Test,Visual Analogue Pain Scale,Analog Pain Scale,Assessment, Pain,McGill Pain Scale,Visual Analog Pain Scale,Analgesia Test,Analog Pain Scales,Analogue Pain Scales,Formalin Tests,Intensity, Pain,Measurement, Pain,Nociception Test,Pain Assessments,Pain Intensities,Pain Measurements,Pain Questionnaire, McGill,Pain Scale, Analog,Pain Scale, Analogue,Pain Scale, McGill,Pain Severities,Pain Test, Tourniquet,Questionnaire, McGill Pain,Scale, Analog Pain,Scale, Analogue Pain,Scale, McGill Pain,Severity, Pain,Test, Analgesia,Test, Formalin,Test, Nociception,Test, Tourniquet Pain,Tests, Nociception,Tourniquet Pain Tests
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004745 Enkephalins One of the three major families of endogenous opioid peptides. The enkephalins are pentapeptides that are widespread in the central and peripheral nervous systems and in the adrenal medulla. Enkephalin
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013373 Substance P An eleven-amino acid neurotransmitter that appears in both the central and peripheral nervous systems. It is involved in transmission of PAIN, causes rapid contractions of the gastrointestinal smooth muscle, and modulates inflammatory and immune responses. Euler-Gaddum Substance P,Hypothalamic Substance P,SP(1-11),Euler Gaddum Substance P,Substance P, Euler-Gaddum,Substance P, Hypothalamic

Related Publications

K Misterek, and I Maszczynska, and A Dorociak, and S W Gumulka, and D B Carr, and S K Szyfelbein, and A W Lipkowski
January 1989, Life sciences,
K Misterek, and I Maszczynska, and A Dorociak, and S W Gumulka, and D B Carr, and S K Szyfelbein, and A W Lipkowski
January 1993, Life sciences,
K Misterek, and I Maszczynska, and A Dorociak, and S W Gumulka, and D B Carr, and S K Szyfelbein, and A W Lipkowski
April 2013, Journal of peptide science : an official publication of the European Peptide Society,
K Misterek, and I Maszczynska, and A Dorociak, and S W Gumulka, and D B Carr, and S K Szyfelbein, and A W Lipkowski
May 2020, European journal of pharmacology,
K Misterek, and I Maszczynska, and A Dorociak, and S W Gumulka, and D B Carr, and S K Szyfelbein, and A W Lipkowski
February 1994, Brain research. Molecular brain research,
K Misterek, and I Maszczynska, and A Dorociak, and S W Gumulka, and D B Carr, and S K Szyfelbein, and A W Lipkowski
July 1984, Neuropharmacology,
K Misterek, and I Maszczynska, and A Dorociak, and S W Gumulka, and D B Carr, and S K Szyfelbein, and A W Lipkowski
June 1985, Neuroscience letters,
K Misterek, and I Maszczynska, and A Dorociak, and S W Gumulka, and D B Carr, and S K Szyfelbein, and A W Lipkowski
January 2000, Neuroscience,
K Misterek, and I Maszczynska, and A Dorociak, and S W Gumulka, and D B Carr, and S K Szyfelbein, and A W Lipkowski
January 2015, Translational neuroscience,
K Misterek, and I Maszczynska, and A Dorociak, and S W Gumulka, and D B Carr, and S K Szyfelbein, and A W Lipkowski
March 2002, The journal of peptide research : official journal of the American Peptide Society,
Copied contents to your clipboard!